Diabetes Care, Vol 23, Issue 5 634-638, Copyright © 2000 by American Diabetes Association

ARTICLES

Efficacy of injected liquid silicone in the diabetic foot to reduce risk factors for ulceration: a randomized double-blind placebo-controlled trial

CH van Schie, A Whalley, L Vileikyte, T Wignall, S Hollis and AJ Boulton
Department of Medicine, Manchester Royal Infirmary, UK. carine@footclinic.demon.co.uk

OBJECTIVE: To investigate the effectiveness of injecting liquid silicone in the diabetic foot to reduce risk factors for ulceration in a randomized double-blind placebo-controlled trial. RESEARCH DESIGN AND METHODS: A total of 28 diabetic neuropathic patients without peripheral vascular disease were randomized to active treatment with 6 injections of 0.2 ml liquid silicone in the plantar surface of the foot or to treatment with an equal volume of saline (placebo). No significant differences were evident regarding age or neuropathy status between the 2 groups. All injections were under the metatarsal heads at sites of calluses or high pressures. Barefoot plantar pressures (pedobarography) and plantar tissue thickness under the metatarsal heads (Planscan ultrasound device) were measured at baseline and at 3, 6, and 12 months after the first injection. Injection sites were photographed at all stages, and callus formation was scored as a change from baseline. Throughout the study, patients were treated by the same podiatrist for all podiatry treatment. RESULTS: Patients who received silicone treatment had significantly increased plantar tissue thickness at injection sites compared with the placebo group (1.8 vs. 0.1 mm) (P < 0.0001) and correspondingly significantly decreased plantar pressures (-232 vs. -25 kPa) (P < 0.05) at 3 months, with similar results at 6 and 12 months. A trend was noted toward a reduction of callus formation in the silicone-treated group compared with no change in the placebo group. CONCLUSIONS: The results confirm the efficacy of plantar silicone injections in reducing recognized risk factors associated with diabetic foot ulceration.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C.-C. Hsu, W.-C. Tsai, C.-L. Wang, S.-H. Pao, Y.-W. Shau, and Y.-S. Chuan Microchambers and macrochambers in heel pads: are they functionally different? J Appl Physiol, June 1, 2007; 102(6): 2227 - 2231. [Abstract] [Full Text] [PDF]

				C. H.M. van Schie, F. Rawat, and A. J.M. Boulton Reduction of Plantar Pressure Using a Prototype Pressure-Relieving Dressing Diabetes Care, September 1, 2005; 28(9): 2236 - 2237. [Full Text] [PDF]

				W. D. Wallace, S. W. Balkin, L. Kaplan, and S. Nelson The Histologic Host Response to Liquid Silicone Injections for Prevention of Pressure-Related Ulcers of the Foot: A 38-Year Study J Am Podiatr Med Assoc, November 1, 2004; 94(6): 550 - 557. [Abstract] [Full Text] [PDF]

				Z. T. Bloomgarden Diabetes Complications Diabetes Care, June 1, 2004; 27(6): 1506 - 1514. [Full Text] [PDF]

				J. Porthouse and D. J. Torgerson The Need for Randomized Controlled Trials in Podiatric Medical Research J Am Podiatr Med Assoc, May 1, 2004; 94(3): 221 - 228. [Abstract] [Full Text] [PDF]

				F. Abouaesha, C. H. M. van Schie, D. G. Armstrong, and A. J. M. Boulton Plantar Soft-Tissue Thickness Predicts High Peak Plantar Pressure in the Diabetic Foot J Am Podiatr Med Assoc, January 1, 2004; 94(1): 39 - 42. [Abstract] [Full Text] [PDF]

				C. N. Dang and A. J. M. Boulton Changing Perspectives in Diabetic Foot Ulcer Management International Journal of Lower Extremity Wounds, March 1, 2003; 2(1): 4 - 12. [Abstract] [PDF]

				F. Abouaesha, C. H.M. van Schie, G. D. Griffths, R. J. Young, and A. J.M. Boulton Plantar Tissue Thickness Is Related to Peak Plantar Pressure in the High-Risk Diabetic Foot Diabetes Care, July 1, 2001; 24(7): 1270 - 1274. [Abstract] [Full Text] [PDF]